Professional Documents
Culture Documents
Interpretation:: Testname Value Unit Bioref - Interval
Interpretation:: Testname Value Unit Bioref - Interval
MOLECULARBIOLOGY
COVID-19(SARSCoV-2) Negative
(Method:RTPCR)
Interpretation:
POSITIVE IndicatesthepresenceofSARS-COV-2viralRNAinthegivenspecimen.
NEGATIVE IndicatestheabsenceofSARS-COV-2viralRNAinthegivenspecimen.
INCONCLUSIVE Targetisinconclusive,Advisedtosendfreshspecimenforrecheck
ICMRRegistrationNoTICPLSDD
SampleType:-Nasopharyngeal&Oropharyngeal
TestIndications:
COVID-19isaninfectiousdiseasecausedbythevirusstrain"severeacuterespiratorysyndromecoronavirus2"(SARS-CoV-
2),Commonsignsofinfectionincluderespiratorysymptoms,fever,cough,shortnessofbreathandbreathingdifficulties.Inmoreseverecases,infectioncancausespneumonia,severeacuterespiratorysyn
dromeandkidneyfailure.
ClinicalSignificance:
COVID19couldbeasymptomaticorpresentwithsymptomsoffever,cough,shortnessofbreath.Severecasescouldleadtopneumonia,severeacuterespiratorysyndromeandsometimesdeath.
OneshouldseekmedicaladviceifasymptomaticpatienthasbeeninclosecontactwithapersonknowntohaveCOVID-
19orliveinorhaverecentlytraveledfromanareawithongoingspreadofCOVID-19. COVID-19 is declared as a pandemic but need to be controlled by early diagnosis and following standard
and droplet precautions to prevent transmission.
Limitationsofthe Assay:
OneormorenegativeresultsdoesnotruleoutthepossibilityofCOVID-
19virusinfection.Anumberoffactorscouldleadtoanegativeresultinaninfectedindividual,includingpoorqualityofthespecimen, low sample volume, timing of specimen collection (late or
very early in the infection), inappropriate sample handling and shipping, inherent technical reasons like virus mutation or PCRinhibition.
Disclaimer:
1. Thistestisintendedforuseinconjunctionwithclinicalpresentationandotherlaboratorymarkers.
2. Improperspecimencollection,handling,storageandtransportationmayresultsinfalsenegativeresults.
3. Thereportrepresentsonlythespecimenreceivedinlaboratory.
**TheLabisNABLaccredited&ICMRapproved.